STERIS Revenue 2010-2022 | STE

STERIS annual/quarterly revenue history and growth rate from 2010 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • STERIS revenue for the quarter ending September 30, 2022 was $1.201B, a 0.3% increase year-over-year.
  • STERIS revenue for the twelve months ending September 30, 2022 was $4.777B, a 24.14% increase year-over-year.
  • STERIS annual revenue for 2022 was $4.585B, a 47.55% increase from 2021.
  • STERIS annual revenue for 2021 was $3.108B, a 2.53% increase from 2020.
  • STERIS annual revenue for 2020 was $3.031B, a 8.94% increase from 2019.
STERIS Annual Revenue
(Millions of US $)
2022 $4,585
2021 $3,108
2020 $3,031
2019 $2,782
2018 $2,620
2017 $2,613
2016 $2,239
2015 $1,850
2014 $1,622
2013 $1,502
2012 $1,407
2011 $1,207
2010 $1,258
2009 $1,299
STERIS Quarterly Revenue
(Millions of US $)
2022-09-30 $1,201
2022-06-30 $1,156
2022-03-31 $1,211
2021-12-31 $1,209
2021-09-30 $1,197
2021-06-30 $968
2021-03-31 $874
2020-12-31 $809
2020-09-30 $756
2020-06-30 $669
2020-03-31 $823
2019-12-31 $774
2019-09-30 $737
2019-06-30 $697
2019-03-31 $768
2018-12-31 $696
2018-09-30 $679
2018-06-30 $639
2018-03-31 $716
2017-12-31 $662
2017-09-30 $634
2017-06-30 $608
2017-03-31 $681
2016-12-31 $647
2016-09-30 $646
2016-06-30 $638
2016-03-31 $690
2015-12-31 $619
2015-09-30 $490
2015-06-30 $440
2015-03-31 $502
2014-12-31 $473
2014-09-30 $463
2014-06-30 $413
2014-03-31 $465
2013-12-31 $406
2013-09-30 $384
2013-06-30 $368
2013-03-31 $428
2012-12-31 $380
2012-09-30 $356
2012-06-30 $337
2012-03-31 $390
2011-12-31 $355
2011-09-30 $343
2011-06-30 $319
2011-03-31 $378
2010-12-31 $328
2010-09-30 $312
2010-06-30 $189
2010-03-31 $332
2009-12-31 $328
2009-09-30 $314
2009-06-30 $284
2009-03-31 $344
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $19.157B $4.585B
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $220.806B 23.09
Edwards Lifesciences (EW) United States $47.328B 32.57
Alcon (ALC) Switzerland $34.365B 29.59
Teleflex (TFX) United States $11.379B 18.46
Fresenius Medical Care AG KGaA (FMS) Germany $9.600B 9.64
Penumbra (PEN) United States $8.008B 1916.82
Globus Medical (GMED) United States $7.483B 38.05
Integer Holdings (ITGR) United States $2.426B 19.47
Glaukos (GKOS) United States $2.281B 0.00
Nevro (NVRO) United States $1.601B 0.00
Paragon 28 (FNA) United States $1.511B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.261B 17.96
Artivion (AORT) United States $0.546B 0.00